OC 32 - Cancer associated thrombosis - Treatment and complications

Moderator(s)

• 

  Vincent Lanting, MD

  PhD student
  Department of Vascular Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands
  Amsterdam, Noord-Holland, Netherlands
• 

  Marc Carrier, MD

  Professor
  Department of Medicine, University of Ottawa at the The Ottawa Hospital
  Ottawa, Ontario, Canada

Presentations:

• 09:30 – 09:45 ICT

  Risk of CAR T-cell therapy-related thrombosis and bleeding: preliminary results of the multicenter ‘Follow that CAR’ registry
  

  Presenting Author: Amica K. Ko, MD MSc – Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands

  Co-Author: Pim G.N.J. Mutsaers – Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

  Co-Author: Frank W.G Leebeek, MD PhD – Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

  Co-Author: Mandy N. Lauw, MD PhD – Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands
• 09:45 – 10:00 ICT

  Growth differentiation factor-15 is associated with risk of major bleeding in patients with cancer: results from a prospective cohort study
  

  Presenting Author: Cornelia Englisch, MD – Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna

  Co-Author: Stephan Nopp – Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna

  Co-Author: Ingrid Pabinger – Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna

  Co-Author: Florian Moik, MD PhD – Medical University of Graz

  Co-Author: Daniel Steiner – Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna

  Co-Author: Angelika M. Starzer – Division of Oncology, Department of Medicine I, Medical University of Vienna

  Co-Author: Monika Fritzer-Szekeres – Department of Laboratory Medicine, Medical University of Vienna;

  Co-Author: Matthias Preusser – Division of Oncology, Department of Medicine I, Medical University of Vienna

  Co-Author: Anna Berghoff – Division of Oncology, Department of Medicine I, Medical University of Vienna

  Co-Author: Cihan Ay, MD – Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna
• 10:00 – 10:15 ICT

  Low-molecular-weight heparin for the prevention of venous thromboembolism in adults with newly diagnosed acute lymphoblastic leukemia; prospective side-study of the HOVON-100 trial
  

  Presenting Author: Mandy N. Lauw, MD PhD – Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

  Co-Author: Anita W. Rijneveld – Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands

  Co-Author: Amica K. Ko, MD MSc – Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands

  Co-Author: Bronno Van der Holt – Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands

  Co-Author: Cathelijne A. Fokkema – Department of Hematology, Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands

  Co-Author: Saskia Middeldorp, MD, PhD – Radboud university medical center

  Co-Author: Frank W.G Leebeek, MD PhD – Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

  Co-Author: Bart J. Biemond – Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands
• 10:15 – 10:30 ICT

  Efficacy and safety of direct oral anticoagulants for treatment of cancer-associated venous thromboembolism in a long-term follow-up. A real-life italian registry (MAC Project)
  

  Presenting Author: Giuseppe Camporese – Padua University Hospital

  Co-Author: Enrico Bernardi – Hospital of Treviso

  Co-Author: Cristiano Bortoluzzi – Hospital of Venice

  Co-Author: Franco Noventa – QUOVADIS Association no-profit

  Co-Author: Elena Campello, PhD – General Internal Medicine Unit and Thrombotic and Hemorrhagic Disease Unit, Department of Medicine, Padova University Hospital, Padova, Italy

  Co-Author: Chiara Simion – University of Padua, Department of Medicine -DIMED

  Co-Author: Luca Spiezia – Padua University Hospital

  Co-Author: Fabio Dalla Valle – Padua University Hospital

  Co-Author: Paolo Scarinzi – Padua University Hospital

  Co-Author: Ngoc Vo Hong – Hospital of Venice

  Co-Author: Egidio Imbalzano – University of Messina

  Co-Author: Pierpaolo Di Micco – PO A Rizzoli, ASL Napoli 2 Nord

  Co-Author: Gaia Gagliardi – Padua University Hospital

  Co-Author: Chiara Di Gesù – Padua University Hospital

  Co-Author: Alessia Pacorini – Padua University Hospital

  Co-Author: Angela Napolitano – Padua University Hospital

  Co-Author: Chiara Tonello – Padua University Hospital

  Co-Author: Michela Nardin – Hospital of Venice

  Co-Author: Paolo Simioni, MD, PhD – University of Padova, Padova University Hospital
• 10:30 – 10:45 ICT

  Interim analysis of the Prospective Cohort Study on Patients with a Haematological Malignancy on Anticoagulants who develop Thrombocytopaenia (HAT Study)
  

  Presenting Author: Marcus P. Lombard, MBBS BMedSc (Hons) – Fiona Stanley Hospital

  Co-Author: Jessica Ling – Fiona Stanley Hospital

  Co-Author: Caitlin Rice, MB Bch BAO DTMH MRCP – Fiona Stanley Hospital, Perth, Western Australia

  Co-Author: Dylan O'Donovan – Sir Charles Gairdner Hospital

  Co-Author: Katherine Creeper – Sir Charles Gairdner Hospital

  Co-Author: Rosslyn De Wet – Sir Charles Gairdner Hospital

  Co-Author: Dominic Pepperell – Department of Thrombosis and Haemostasis, Fiona Stanley Hospital, Perth, Western Australia, Australia

  Co-Author: Stephanie P'ng – The Haemophilia and Haemostasis Centre, Fiona Stanley Hospital, Murdoch, Australia